Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (41-50 of 259) with videos related to

Pageof 26
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 2, 2008
Sex difference in the association of the angiotensin converting enzyme I/D polymorphism and body mass indexMichael J Wacker, Michael P Godard, Everlee H McCabe, et al.
Stroke|January 18, 2005
Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS)Dominick J H McCabe, Anthony C Pereira, Andrew Clifton, et al.
The American Journal of Cardiology|May 9, 1988
Initial success and long-term follow-up of percutaneous transluminal coronary angioplasty in chronic total occlusions versus conventional stenosesR D Safian, C H McCabe, M E Sipperly, et al.
Journal of the American Geriatrics Society|January 1, 1992
PTCA in the elderly: the "young-old" versus the "old-old"D E Forman, A D Berman, C H McCabe, et al.
European Heart Journal|January 17, 2002
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUSD A Morrow, E M Antman, S M Snapinn, et al.
American Heart Journal|June 20, 2006
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trialDavid A Morrow, Benjamin M Scirica, Ewa Karwatowska-Prokopczuk, et al.
American Heart Journal|May 3, 2005
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trialCharles S Smith, Christopher P Cannon, Carolyn H McCabe, et al.
Journal of the American College of Cardiology|February 14, 1998
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudyE M Antman, D B Sacks, N Rifai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2003
Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective seriesG C Cloud, F Crawley, A Clifton, et al.
European Heart Journal|February 3, 2005
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trialDavid A Morrow, Sabina A Murphy, Carolyn H McCabe, et al.
Pageof 26

Showing results (41-50 of 259) with videos related to

Sort By:
Pageof 26
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 2, 2008
Sex difference in the association of the angiotensin converting enzyme I/D polymorphism and body mass indexMichael J Wacker, Michael P Godard, Everlee H McCabe, et al.
Stroke|January 18, 2005
Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS)Dominick J H McCabe, Anthony C Pereira, Andrew Clifton, et al.
The American Journal of Cardiology|May 9, 1988
Initial success and long-term follow-up of percutaneous transluminal coronary angioplasty in chronic total occlusions versus conventional stenosesR D Safian, C H McCabe, M E Sipperly, et al.
Journal of the American Geriatrics Society|January 1, 1992
PTCA in the elderly: the "young-old" versus the "old-old"D E Forman, A D Berman, C H McCabe, et al.
European Heart Journal|January 17, 2002
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUSD A Morrow, E M Antman, S M Snapinn, et al.
American Heart Journal|June 20, 2006
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trialDavid A Morrow, Benjamin M Scirica, Ewa Karwatowska-Prokopczuk, et al.
American Heart Journal|May 3, 2005
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trialCharles S Smith, Christopher P Cannon, Carolyn H McCabe, et al.
Journal of the American College of Cardiology|February 14, 1998
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudyE M Antman, D B Sacks, N Rifai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2003
Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective seriesG C Cloud, F Crawley, A Clifton, et al.
European Heart Journal|February 3, 2005
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trialDavid A Morrow, Sabina A Murphy, Carolyn H McCabe, et al.
Pageof 26